Eddy Pasquier & Marion LeGrand on druggable cancer vulnerabilities
eBioMedicine in conversation with - A podcast by The Lancet Group
Categorie:
Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma. Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00317-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://fac...
